Europska Unija - talijanski - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

almus s.r.l. - metformina - metformina

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - metformina - metformina

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

laboratori guidotti s.p.a. - metformina - metformina

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

pharmacare s.r.l. - metformina - metformina

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

galenicum health, s.l. - metformina e sitagliptina - metformina e sitagliptina

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

inventia healthcare bv - metformina - metformina

Europska Unija - talijanski - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

krka d.d. novo mesto - metformina e vildagliptin - metformina e vildagliptin

Italija - talijanski - AIFA (Agenzia Italiana del Farmaco)

viatris limited - metformina e vildagliptin - metformina e vildagliptin